Pregabalin - NDC Database (Page 31)

660 records found
Page:First PagePrevious Page31Next PageLast Page
76420-118 Jul 19, 2019
Pregabalin 50 mg Oral Capsule by Asclemed USA, Inc.
76420-119 Jul 19, 2019
Pregabalin 75 mg Oral Capsule by Asclemed USA, Inc.
76420-120 Jul 19, 2019
Pregabalin 100 mg Oral Capsule by Asclemed USA, Inc.
76420-121 Jul 19, 2019
Pregabalin 150 mg Oral Capsule by Asclemed USA, Inc.
76420-122 Jul 19, 2019
Pregabalin 200 mg Oral Capsule by Asclemed USA, Inc.
76420-123 Jul 19, 2019
Pregabalin 225 mg Oral Capsule by Asclemed USA, Inc.
76420-124 Jul 19, 2019
Pregabalin 300 mg Oral Capsule by Asclemed USA, Inc.
76420-221 Mar 31, 2020
Pregabalin 75 mg Oral Capsule by Asclemed USA, Inc.
76420-247 Mar 31, 2020
Pregabalin 50 mg Oral Capsule by Asclemed USA, Inc.
76420-248 Mar 31, 2020
Pregabalin 100 mg Oral Capsule by Asclemed USA, Inc.
76420-249 Mar 31, 2020
Pregabalin 150 mg Oral Capsule by Asclemed USA, Inc.
76420-583 Jun 20, 2022
Pregabalin 100 mg Oral Capsule by Asclemed USA, Inc.
76420-656 Jun 20, 2022
Pregabalin 50 mg Oral Capsule by Asclemed USA, Inc.
76420-657 Jun 20, 2022
Pregabalin 75 mg Oral Capsule by Asclemed USA, Inc.
76420-658 Jun 20, 2022
Pregabalin 150 mg Oral Capsule by Asclemed USA, Inc.
76420-659 Jun 20, 2022
Pregabalin 200 mg Oral Capsule by Asclemed USA, Inc.
76420-660 Jun 20, 2022
Pregabalin 225 mg Oral Capsule by Asclemed USA, Inc.
76420-661 Jun 20, 2022
Pregabalin 300 mg Oral Capsule by Asclemed USA, Inc.
76420-662 Jun 20, 2022
Pregabalin 25 mg Oral Capsule by Asclemed USA, Inc.
80425-0025 Jul 19, 2019
Pregabalin 50 mg Oral Capsule by Advanced Rx Pharmacy of Tennessee, LLC
Page:First PagePrevious Page31Next PageLast Page
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.